Scarica l'app Stockscreener
34.29
5.43%
-1.97
Dopo l'orario di chiusura:
33.81
-0.48
-1.40%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Storia dei dividendi
Precedente Chiudi:
$36.26
Aprire:
$36.09
Volume 24 ore:
3.11M
Relative Volume:
1.42
Capitalizzazione di mercato:
$5.22B
Reddito:
$3.44B
Utile/perdita netta:
$-8.30M
Rapporto P/E:
-230.60
EPS:
-0.1487
Flusso di cassa netto:
$43.30M
1 W Prestazione:
-13.56%
1M Prestazione:
+1.69%
6M Prestazione:
-9.14%
1 anno Prestazione:
-13.93%
Intervallo 1D:
$33.80
$36.78
Intervallo di 1 settimana:
$33.80
$38.84
Portata 52W:
$28.53
$56.22
Bruker Corp Stock (BRKR) Company Profile
Nome
Bruker Corp
Settore
Industria
Telefono
978663-3660
Indirizzo
40 MANNING RD, BILLERICA, MA
Compare BRKR vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BRKR
Bruker Corp
|
34.29 | 5.52B | 3.44B | -8.30M | 43.30M | -0.1487 |
ABT
Abbott Laboratories
|
91.33 | 163.10B | 45.13B | 6.28B | 7.40B | 3.5895 |
SYK
Stryker Corp
|
315.13 | 123.10B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
79.37 | 105.15B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
57.15 | 86.87B | 20.62B | 3.56B | 3.66B | 2.3847 |
EW
Edwards Lifesciences Corp
|
81.22 | 47.44B | 6.30B | 1.07B | 1.34B | 1.8406 |
Bruker Corp Stock (BRKR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-10 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2025-12-09 | Iniziato | Goldman | Sell |
| 2025-11-20 | Iniziato | Rothschild & Co Redburn | Buy |
| 2025-05-22 | Downgrade | Citigroup | Buy → Neutral |
| 2024-12-19 | Iniziato | Guggenheim | Buy |
| 2024-12-10 | Iniziato | UBS | Neutral |
| 2024-12-05 | Aggiornamento | Goldman | Sell → Neutral |
| 2024-10-15 | Iniziato | Barclays | Overweight |
| 2024-09-30 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2024-08-28 | Iniziato | Wells Fargo | Overweight |
| 2024-06-03 | Ripresa | Jefferies | Buy |
| 2024-02-14 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2023-12-19 | Iniziato | Wells Fargo | Equal Weight |
| 2023-12-13 | Iniziato | Wolfe Research | Outperform |
| 2022-10-21 | Iniziato | UBS | Buy |
| 2022-08-22 | Aggiornamento | Citigroup | Neutral → Buy |
| 2021-10-15 | Ripresa | Cowen | Market Perform |
| 2021-06-15 | Aggiornamento | Cleveland Research | Neutral → Buy |
| 2021-02-05 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2020-12-02 | Iniziato | Goldman | Sell |
| 2020-11-16 | Aggiornamento | Wolfe Research | Underperform → Peer Perform |
| 2020-05-01 | Downgrade | Cleveland Research | Buy → Neutral |
| 2020-04-02 | Downgrade | Wolfe Research | Peer Perform → Underperform |
| 2020-04-01 | Downgrade | Needham | Strong Buy → Hold |
| 2020-03-26 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2020-01-08 | Iniziato | Wells Fargo | Overweight |
| 2020-01-07 | Iniziato | Citigroup | Buy |
| 2019-11-15 | Iniziato | Stifel | Hold |
| 2019-09-26 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2019-07-15 | Aggiornamento | Goldman | Sell → Neutral |
| 2019-06-24 | Reiterato | Needham | Strong Buy |
| 2019-06-21 | Reiterato | BofA/Merrill | Neutral |
| 2019-05-30 | Iniziato | Wolfe Research | Peer Perform |
| 2019-05-06 | Reiterato | Needham | Strong Buy |
| 2019-05-03 | Aggiornamento | SVB Leerink | Mkt Perform → Outperform |
| 2019-05-03 | Aggiornamento | UBS | Sell → Neutral |
| 2019-04-12 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2019-02-12 | Reiterato | BTIG Research | Buy |
| 2019-01-03 | Iniziato | Needham | Strong Buy |
Mostra tutto
Bruker Corp Borsa (BRKR) Ultime notizie
Analysts Estimate Bruker (BRKR) to Report a Decline in Earnings: What to Look Out for - Yahoo! Finance Canada
Bruker (BRKR) Expected to Announce Quarterly Earnings on Wednesday - MarketBeat
Bruker enhances MALDI and IR Biotyper for infection control - SelectScience
Bruker unveils MyGenius PRO diagnostics system - MSN
Bruker (NASDAQ: BRKR) sets $3.9844 dividend on 6.375% preferred - Stock Titan
Bruker announces Q2 preliminary revenue between $795M and $798M; shares decline over 3.5% - MSN
Universal Beteiligungs und Servicegesellschaft mbH Sells 135,470 Shares of Bruker Corporation $BRKR - MarketBeat
Bruker Corp (BRKR) Stock Price, Trades & News - GuruFocus
Bruker acquires Austria based biocrates - MSN
Bruker Announces Date and Time of First Quarter 2026 Earnings Release and Webcast - ChartMill
Peregrine Capital Management LLC Raises Holdings in Bruker Corporation $BRKR - MarketBeat
Omics-Based Clinical Trials Research Report 2026: $47.78 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F - GlobeNewswire Inc.
Bruker Corp (BRKR) Stock Down 8.7% -- Now Undervalued? GF Score: 81/100 - GuruFocus
Bruker (NASDAQ:BRKR) Stock Price Down 8.7%Time to Sell? - MarketBeat
Trending Industry Today: Bruker Corp Leads Losses In Room-Temp Superconductors Stocks - Moomoo
BRKRP Forecast, Price Target & Analyst Ratings | BRUKER CORPBRKR 6 3/8 09/01/28 (NASDAQ:BRKRP) - ChartMill
Is Bruker (BRKR) Fairly Priced After Recent Short Term Share Price Rebound? - Yahoo Finance
BRKR Financials: Income Statement, Balance Sheet & Cash Flow | Bruker Corp - Stock Titan
Bruker Corp. Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo
Bruker Corp. Opens with 6.41% Gain, Marking Significant Gap Up in Stock Performance - Markets Mojo
Bruker Corp stock (US1167941087): Is its scientific instruments edge strong enough for steady growth - AD HOC NEWS
Bruker, Amneal, Amphastar Pharmaceuticals, Dentsply Sirona, and PacBio Stocks Trade Up, What You Need To Know - Yahoo Finance
Bruker Launches MyGenius PRO® High-Throughput Sample-to-Answer M - GuruFocus
Bruker (BRKR) Unveils Innovations for Cancer Research at Upcomin - GuruFocus
A Look at Bruker Corp (BRKR) After 4.5% Gain -- GF Value $71.47 vs Price $40.70 - GuruFocus
Bruker unveils spatial biology workflows, opens PaintScape pre-orders By Investing.com - Investing.com Canada
Bruker Launches MyGenius PRO Automated Molecular Diagnostics System in Europe - Contract Pharma
Bruker Spatial Biology Showcases High Fidelity Spatial Data and Integrated Multi-platform Workflows for Unprecedented Multiomic Insights at AACR 2026 - Moomoo
Bruker expands microbiology portfolio with new testing tools By Investing.com - Investing.com South Africa
Bruker unveils spatial biology workflows, opens PaintScape pre-orders - Investing.com
Bruker expands microbiology portfolio with new testing tools - Investing.com
Bruker launches automated molecular diagnostics system in Europe - Investing.com
Bruker Launches MyGenius PRO® High-Throughput Sample-to-Answer Molecular Diagnostics System at ESCMID 2026 - Bakersfield.com
Bruker Corporation (NASDAQ:BRKR) Receives Average Recommendation of "Hold" from Brokerages - MarketBeat
Mark Munch Sells 2,000 Shares of Bruker (NASDAQ:BRKR) Stock - MarketBeat
Bruker (BRKR) EVP Mark Munch sells 2,000 shares after option exercise - Stock Titan
BRKR (NASDAQ: BRKR) director sale notice — 2,000 shares via option - Stock Titan
Bruker (NASDAQ:BRKR) Upgraded at TD Cowen - MarketBeat
BRKR SEC FilingsBruker Corp 10-K, 10-Q, 8-K Forms - Stock Titan
Barclays Maintains Bruker Corp(BRKR.US) With Buy Rating, Cuts Target Price to $45 - 富途牛牛
Why Bruker (BRKR) Stock Is Up Today - Yahoo Finance
Bruker (BRKR) Unveils Innovative NMR Products at Experimental Co - GuruFocus
CA-BRUKER-CORP - Black Hills Pioneer
Bruker rolls out NMR tools with 30,000x signal boost, more automation - Stock Titan
Bruker Corp Azioni (BRKR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.30%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):